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A three-component reaction of 3-substituted coumarins with N-alkyl-a-amino acids and aldehydes gave
1-benzopyrano[3,4-c]pyrrolidines as a result of a 1,3-dipolar cycloaddition of an intermediate non-
stabilized azomethine ylide at the double bond of the coumarin system in moderate to good yields. In
most cases, high regio- and stereo-selectivity of the [3þ2] cycloaddition was observed.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
A decarboxylative reaction of N-alkyl-a-amino acids with car-
bonyl compounds is one of themost convenientmethods to generate
nonstabilized azomethine ylides for [3þ2] cycloaddition with
electron-deﬁcient alkenes.1 As this method has been developed
relatively recently, by Grigg and Tsuge in the late 1980s, the chem-
istry of nonstabilized azomethine ylides obtained in these reactions
is studied signiﬁcantly less in comparison with other 1,3-dipoles.2
Their reactions with 3-substituted coumarins are interesting, ﬁrst,
to study the regio- and stereo-selectivity of the cycloaddition with
asymmetric trisubstituted alkenes; second, in view of the biological
activity of adducts.
It has been found that R,R-benzopyranopyrrolidine 1 is an a1
adrenoreceptor antagonist, whereas R,R-benzopyranopyrrolidine 2 is
an antagonist of 5-HT2C receptors with respect to 5-HT2A.3 Benzo-
pyranopyrrolidine 1 named Fiduxosin shows an a1a/a1b selectivity
for adrenoreceptors; it was suggested as a promising pharmaceutical
agent for the treatment of benign prostatic hyperplasia.3f Very
recently, the synthesis of isomeric 2-benzopyranopyrrolidine 3,
which was found to be serotonin 5-HT2C receptor agonist has been
reported3g (Fig. 1).mail address: mvslc@mail.ru
All rights reserved.The key stage in the synthesis of compounds 1 and 2 consists of
a cycloaddition of nonstabilized azomethine ylides onto benzopyr-
anones; however, information about such reactions in the coumarin
series was quite limited.2e,f,3g In a preliminary communication,4 we
described the synthesis of 1-benzopyrano[3,4-c]pyrrolidines from
3-substituted coumarins and a symmetric azomethine ylide derived
from sarcosine and formaldehyde. [3þ2] cycloaddition of these
coumarins with asymmetric ylides generated from proline andFig. 1. Benzopyranopyrrolidine drugs candidates.
Fig. 2. Diagnostic 1H NMR signals and NOE correlations of benzopyranopyrrolidine
oxalate 5a.
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e5892 5885formaldehyde or benzaldehyde gave one diastereomer after crys-
tallization of salts and indicated a good selectivity of the reaction.
Given the broad utility of benzopyranopyrrolidines in medicinal
chemistry and continuing our research in this ﬁeld,5,6 we have ex-
tended this to a number of coumarins and azomethine ylides, as well
as isolating some minor diastereomers and establishing their struc-
tures. In addition, the study of the chemical properties of the adducts
has begun.
2. Results and discussion
2.1. 1,3-Dipolar cycloaddition of nonstabilized azomethine
ylides with 3-substituted coumarins
We have found that reﬂuxing of sarcosine, paraformaldehyde
and coumarins 4aee in benzene for 4e6 h with azeotropic removal
of water results in benzopyranopyrrolidine derivatives 5aee (yields
76e92%) (Scheme 1). Treatment of products 5a,c with oxalic acid
provided conversion of these liquid pyrrolidines into analytically
pure crystalline oxalates without chromatographic puriﬁcation.
Adducts 5b,d,e were puriﬁed by ﬂash chromatography using silica
gel. On the other hand, 3-methylcoumarin reacts very sluggishly
with this ylide, and after reﬂuxing for 7 h only 27% of the desired
product was observed in the crude reaction mixture according to
the 1H NMR spectroscopic data.Scheme 1. Synthesis of 2-methyl-4-oxo-1,2,3,3a,4,9b-hexahydrochromeno[3,4-c]pyr-
roles 5aee.
Scheme 2. Reaction with asymmetrical azomethine ylides from sarcosine and
cyclohexanone.The structures of products 5aeewere determined by elemental
analyses, HRMS and their 1H and 13C NMR spectra as well as 2D
1He13C HMQC, HMBC, and 1He1H NOESYexperiments. The 1H NMR
spectra of oxalates 5a,c,d in DMSO-d6 contain the characteristic
signals: a doublet of doublets for the H-10 proton at d 2.7e3.0 ppm,
which is subject to the shielding effect of the benzene moiety in the
cis-position; a triplet for H-100 at d 3.2e3.6 ppm (this proton man-
ifests itself at d 3.20e3.27 ppm in the presence of an ethox-
ycarbonyl or dimethylamide group at the 1,3-cis-position that show
a shielding effect7); two doublet of doublets or two doublets for the
H-30 and H-300 geminal protons at d 3.3e3.8 ppm (Jgem¼10e11 Hz);
a quartet or a triplet for the H-9b benzyl proton at d 3.88e3.94 ppm
(J¼7e9 Hz). The signals for the H-6 and H-8 aromatic protons are
observed at d 7.03e7.06 and 7.14e7.17 ppm, respectively, whereas
the partially overlapping signals for H-7 and H-9 appeared at
d 7.25e7.35 ppm. It is well known that synchronism of the reactions
of nonstabilized azomethine ylides with alkenes results in a cis-
fusion in the new pyrrolidine ring.1e3 This was conﬁrmed in the
1He1H NOESY experiment of the oxalate 5a by considering the
cross-peaks intensities of proton H-9b with H-10, H-100, and H-3a
(Fig. 2).Reaction of 3-substituted coumarins with the asymmetrical
nonstabilized azomethine ylide generated in situ by the conden-
sation of sarcosine and cyclohexanone led to unexpected results
(Scheme 2). This ylide reactedwith coumarins 4c,e to give 4-aryl-2-
pyrrolidones 6c,e as the major products in 30% and 47% yields,
respectively. A possible mechanism for their formation has been
described previously.5 For this reason, the yields of adducts 7c,e
resulting from the classical 1,3-dipolar cycloaddition were consid-
erably reduced (17% and 20%, respectively). Compounds 7c,e were
isolated from a crude reaction mixture by simple acidiﬁcation with
dilute HCl (5 equiv) followed by separation of the aqueous layer,
neutralizationwith NaHCO3, and subsequent ﬂash chromatography
over silica gel (Scheme 2).We have also examined the cycloaddition behaviour of proline
and formaldehyde using coumarins 4 as the trapping dipolar-
ophiles and found that fused pyrrolizidines 8 are produced as the
major products (Scheme 3). The reactions of coumarins 4a,b with
proline and formaldehyde resulted in the formation of complex and
difﬁcult to separate mixtures of isomers and their hydrolysis
products. In contrast, coumarins 4ceg gave much more stable ad-
ducts. According to the 1H NMR data, the crude reaction mixture of
the cycloadditionwith 3-ethoxycarbonylcoumarin (4c) consisted of
four diastereomers with the stereochemistry as shown (Scheme 3).
Fig. 3. 1He1H NOESY data of pyrrolizidines 8ce11c.
Couma-
rin R
Ratio in a crude mixture
(%)a Yield (%)b4 8 9 10 11
c CO2Et 60 19 15 6 47
d CONMe2 did not measure 60
e PO(OEt)2 62 19 14 5 44
f COPh 62 18 15 5 50
g Me 0 6 3 91 41c
a The ratio was determined from 1H and 31P NMR data.
b Yield of 8.
c Yield of 11.
Scheme 3. Reaction of coumarins 4ceg with proline and formaldehyde.
Fig. 4. Plausible transition states for compounds 11e and 12.
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e58925886The major reaction product was 8c (60%) but in addition, small
amounts of 9c (19%) as well as 10c (15%) and 11c (6%) could also be
detected. Three of them, 8c, 9c and 10c, were isolated by column
chromatography and their structures were clearly established on
the basis of 1D and 2D NMR spectroscopic data. Coumarin-3-
phosphonate (4e) reacted with the ylide derived from proline and
paraformaldehyde in a similar manner, and the major adduct 8e
and one minor diastereomer 9e were isolated by column chroma-
tography. Furthermore, compounds 8c,e could also be obtained
without the use of chromatography, by simple recrystallization
of oxalates from ethanol. A similar cycloaddition was also
found to occur when 3-dimethylcarbamoylcoumarin (4d) and
3-benzoylcoumarin (4f) were used. In this case, pyrrolizidines 8d,f
were obtained after recrystallization of the crude oxalates in good
yields. In contrast to this, the reaction of 3-methylcoumarin (4g)
under the same conditions led to the formation of the essentially
one diastereomer 11g, which was isolated as the hydrochloride in
41% yield. This compound was the main component of the reaction
mixture (91% according to the 1H NMR spectrum) (Scheme 3).
On the basis of compounds 8ce11c, obtained from
3-ethoxycarbonylcoumarin (4c), one can see how the structures of
all the products 8e11 were established (Fig. 3). The two pairs of
regioisomers are easily distinguished according to the 1H NMR
data, because they have different proton multiplicity in the central
pyrrolidine ring (in pair 9 and 10 there is an isolated methylene
group). The stereochemistry of 8ce11c was assigned by 1He1H
NOESY experiments. In the case of diastereomers 8c and 11c, there
is a cross-peak for the deshielded H-1100 with H-9 (isomer 8c) anda cross-peak for shielded H-110 with H-9 (isomer 11c). Stereoiso-
mers 9c and 10c differ in the chemical shifts of the methine proton
H-11a. In the case of trans-fusion in the pyrrolizidine 10c, this
proton was observed at a 0.65 ppm higher magnetic ﬁeld than that
of 9c with cis-fusion, probably due to a shielding effect of the
benzene ring.4,7 In addition, a strong NOE cross-peak was observed
between H(11a)eH(11b) in isomer 9c. The structures of products
8e11 were conﬁrmed by elemental analyses, HRMS, 13C NMR
spectra as well as 2D 1He13C HMQC and HMBC experiments.
In general, all coumarins with an electron-withdrawing group in
the 3-position reacted with the azomethine ylide derived from
proline and formaldehyde in a similar manner. A favourable tran-
sition state taking into account molecule polarity would lead to
stereoisomers exo-8 and endo-11. Apparently, the second endo-di-
rection was almost completely suppressed by the unfavourable
steric interactions of the hydrogens of the azomethine ylide and
the pyrone core (Fig. 4). In the case of 3-methylcoumarin, the
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other isomers. Probably, the crucial change in cycloaddition selec-
tivity is associated with domination of steric interactions of the
ylide with the coumarin methyl group.
To our knowledge, very little information is available on the
generation of an azomethine ylide from pipecolic acid and form-
aldehyde. It has only been reported that 1,2-diaroylethenes react to
give a mixture of the isomeric perhydroindolizines.8 We found that
the reaction of coumarin-3-phosphonate (4e) with pipecolic acid
and paraformaldehyde gave a mixture of the corresponding four
stereoisomers 12 (35%), 13 (34%), 14 (18%), and 15 (13%). These
indolizidines have been separated by column chromatography but
the main products 12 and 13 still were as a mixture (39% of 12 and
61% of 13). As in the case of cycloaddition reactions involving
proline, similar NOE cross-peaks revealed the stereochemistry of
isomers 12e15 (Scheme 4).Scheme 4. Synthesis of indolizidines 12e15.
Scheme 5. Reaction of coumarins 4c,e with proline and benzaldehyde.The selectivity of this azomethine ylide interaction differs from
the interaction of the ylide derived from proline and formaldehyde.
Apparently such distinction is due to the size and ﬂexibility of its
cyclic moiety. The absence of adverse steric interactions between
the hydrogen atoms of the bigger non-planar ylide with the cou-
marin pyran ring signiﬁcantly increases endo-cycloaddition (Fig. 4).
In addition to paraformaldehyde and cyclohexanone, benzal-
dehyde was brieﬂy examined in the reaction. Cycloaddition of
3-ethoxycarbonylcoumarin (4c) with the azomethine ylide derived
from proline and benzaldehyde resulted in a mixture of a large
number of pyrrolizidines. Two of them, 16c and 17c, are the major
products and were isolated as a 36:64 mixture, respectively, by
column chromatography in 37% yield. Alternative separation of the
isomers, conversion to the hydrochlorides and crystallization from
ethyl acetateeacetone mixture, allowed us to obtain pure di-
astereomer 17c as the hydrochloride in 26% yield. Coumarin-3-
phosphonate (4e) reacted in a similar way to give adducts 16e
and 17e as free bases after column chromatography in 33% and 21%
yields, respectively (Scheme 5).
The 1H NMR spectra of the resulting products allowed us to
establish their stereochemistry only partially. An alternative
regioisomer can be ruled out from consideration because of the
multiplicity of the benzylic proton H-11, which appeared asa doublet. Signiﬁcantly shielded signals for benzylic protons H-11
and H-11a in diastereomers 16 allows us to assign the phenyl rings
as trans-arranged. Strong evidence for the structures 16c,e and
17c,e was obtained from the 1He1H NOESY experiments. The
most informative cross-peaks for these compounds are as follows:
H-11/H-11a (for 17) and H-11/H-9 (for 16 and 17). The structure of
hydrochloride 17c has been conﬁrmed using X-ray diffraction data.4
This 1,3-dipolar cycloaddition occurs with anti-azomethine
ylide B via two different transition states following from structures
16 and 17. The formation of the ylide B can be explained by the
higher stability of trans-azalactone A that is initially formed in the
reaction of proline with benzaldehyde. Concerted cycloreversion of
the azalactone ring in A with extrusion of carbon dioxide follows
a disrotatory pathway to give anti-ylide B. Apparently, the isom-
erization of dipoles B and C have small rate constants, and the re-
action of B with coumarins 4e,c becomes the main direction
(Scheme 6).2e,f
2.2. Representative reactions of compounds 5
In the second part of this work, we studied some reactions of
compounds 5 (Scheme 7). It was found that 1-benzopyrano[3,4-c]
pyrrolidine 5e readily undergoes quaternizationwithmethyl iodide
to give salt 18 in high yield. Brieﬂy reﬂuxing 5e in methanol
resulted in the opening of the dihydrocoumarin ring to formmethyl
ether 19. It should be noted that heating of 19e on a rotary evap-
orator greater than 70 C promotes a reverse reaction. Reduction
with sodium borohydride in ethanol led to corresponding alcohol
with concomitant recyclization to produce compound 20. The
structures of products 18e20 were deduced from their satisfactory
elemental and spectroscopic (1H, 31P NMR, and HRMS) studies
(Scheme 7).
Oxalates 5b,d were found to be highly hygroscopic compounds.
Judging by the 1H NMR spectra, they undergo partial hydrolysis in a
DMSO-d6 solution with opening of the dihydrocoumarin ring (a set
of the aromatic phenolic protons was observed at d 6.7e7.1 ppm).
Scheme 6. A plausible reaction route to compounds 16 and 17.
Scheme 8. A nucleophilic ring-opening of 5a,b.
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resulted in opening of the dihydrocoumarin ring by water to form a
corresponding amino acid 21 (Scheme 8). Clearly, it is due to the
presence of a good leaving phenolate group, and the basic nitrogen
atom. It should be noted that salts of pyrrolidines 5a,c are
more resistant to nucleophiles; oxalates can be puriﬁed
by recrystallization from ethanol (prolonged heating in ethanol
leads to their partial ring-opening). Benzopyranopyrrolidine 5aScheme 7. Reactions of the adduct 5e.smoothly reacted with piperidine to produce amide 22 in 85% yield
(Scheme 8).
3. Conclusion
The use of 3-substituted coumarins, N-alkyl-a-amino acids and
aldehydes in [3þ2] cycloadditions gives 1-benzopyrano[3,4-c]pyr-
rolidine derivatives with good regio- and stereo-selectivity,
depending on the nature of a substituent in the pyranone ring.
These products are interesting in view of their potential biological
activity, as well as being building blocks in pharmaceutical chem-
istry. A general chemical property of these adducts to undergo
nucleophilic ring-opening of the pyranone cycle was described.
4. Experimental
4.1. General
NMR spectra were obtained on a Jeol ECX-400 spectrometer
operating at 400 MHz for 1H (TMS), 162 MHz for 31P (H3PO4) and
101 MHz for 13C (TMS). All measurements were recorded in DMSO-
d6 or CDCl3 solutions. IR spectra were recorded on a Thermo Sci-
entiﬁc Nicolet 6700 Fourier IR spectrometer (ATIR). Mass spec-
trometry was established on a MicroTOF-Q ﬁtted with an ESI
source. Elemental analysis was performed on PerkineElmer CHN
PE 2400. Analytical TLCs were performed with silica gel 60 F254
plates. Visualization was accomplished by UV light or iodine va-
pour. Column chromatography was carried out using silica gel 60
(230e400 mesh ASTM). Melting points were determined without
correction.
4.2. General procedure for the synthesis of 2-methyl-
1,3,3a,9b-tetrahydrochromeno[3,4-c]pyrrol-4(2H)-ones (5aee)
A stirred mixture of the corresponding coumarin 4 (1.0 mmol),
paraformaldehyde (0.05 g, 1.7 mmol) and ﬁnely ground sarcosine
(0.11 g, 1.2 mmol) was reﬂuxed in dry benzene (8 mL) with removal
of the water formed by means of a DeaneStark trap. Reﬂux was
continued for 4e7 h. The resulting mixture was cooled to room
temperature and slowly ﬁltered through a thin layer of silica gel,
thenwashed with benzene. The colourless solutionwas evaporated
in vacuo to give a crude product. Liquid adducts 5a,c were con-
verted to the oxalate form. Anhydrous oxalic acid (0.10 g, 1.1 mmol)
dissolved in hot acetone (1.5 mL) was added with stirring to the
crude product in hot acetone (1.5 mL). The mixture was reﬂuxed for
an additional 5 min with partial evaporation of acetone (to 2 mL).
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e5892 5889After cooling to 5 C, the solid that formed was ﬁltered off and
washed with dry acetone. The colourless powder was dried to
a constant weight.
4.2.1. (3aS*,9bS*)-2-Methyl-1,3,3a,9b-tetrahydrochromeno[3,4-c]
pyrrol-4(2H)-one oxalate (5a). Yield 78%, a colourless powder, mp
191e193 C; IR: 2486, 1759, 1716, 1649, 1456, 1221, 1185, 1165, 763,
698 cm1; 1H NMR (400 MHz, DMSO-d6) d 2.66 (s, 3H, MeN), 2.98
(t, J¼10.0 Hz, 1H, H-10), 3.45 (dd, J¼10.8, 4.2 Hz, 1H, H-30), 3.56
(t, J¼9.0 Hz, 1H, H-100), 3.64 (t, J¼10.0 Hz, 1H, H-300), 3.72 (td, J¼8.8,
4.2 Hz, 1H, H-3a), 3.88 (q, J¼9.0 Hz, 1H, H-9b), 7.03 (d, J¼8.1 Hz, 1H,
H-6), 7.14 (t, J¼7.5 Hz, 1H, H-8), 7.30 (t, J¼8.1 Hz, 1H, H-7), 7.32
(d, J¼7.5 Hz, 1H, H-9); 13C NMR (101 MHz, DMSO-d6) d 37.5 (C-9b),
40.0 (C-3a), 40.9 (MeN), 57.1 (C-3), 60.0 (C-1), 116.7 (C-6), 119.4
(C-9a), 124.8 (C-8), 129.1 (C-7), 129.3 (C-9), 150.1 (C-5a), 164.2
(CO2H), 167.3 (C-4). Anal. Calcd for C12H13NO2$(CO2H)2: C, 57.34; H,
5.16; N, 4.78. Found: C, 57.06; H, 4.98; N, 4.81.
4.2.2. (3aS*,9bR*)-2-Methyl-4-oxo-1,2 ,3 ,3a,4,9b-hexahy-
drochromeno[3,4-c]pyrrole-3a-carbonitrile (5b). Yield 76%, a yellow
viscous oil; 1H NMR (400 MHz, CDCl3) d 2.39 (s, 3H, Me), 2.78
(dd, J¼9.5, 6.4 Hz, 1H, H-10), 3.23 (t, J¼9.2 Hz, 1H, H-100), 3.31
(d, J¼9.8 Hz, 1H, H-30), 3.57 (d, J¼9.8 Hz, 1H, H-300), 4.00 (dd, J¼8.6,
6.4 Hz,1H, H-9b), 7.10 (d, J¼8.1 Hz,1H, H-6), 7.18e7.23 (m, 2H, ArH),
7.31e7.36 (m, 1H, ArH); HRMS (ESI) calcd for (C13H12N2NaO2)þ
[MþNa]þ: 251.0791, found: 251.0799.
4.2.3. (3aS*,9bR*)-Ethyl 2-methyl-4-oxo-1,2,3,3a,4,9b-hexahy-
drochromeno[3,4-c]pyrrole-3a-carboxylate oxalate (5c). Yield 84%,
a colourless powder, mp 164e166 C; IR: 1766, 1744, 1659, 1252,
1165, 1144, 1099, 758, 691 cm1; 1H NMR (400 MHz, DMSO-
d6þCD3CO2D) d 1.10 (t, J¼7.1 Hz, 3H, Me), 2.40 (s, 3H, MeN), 2.68
(dd, J¼9.1, 8.4 Hz, 1H, H-10), 3.22 (t, J¼8.8 Hz, 1H, H-100), 3.41 (AB-
system, J¼10.1 Hz, 2H, 3-CH2), 3.90 (t, J¼8.4 Hz, 1H, H-9b), 4.10 (q,
J¼7.1 Hz, 2H, OCH2), 7.06 (d, J¼8.2 Hz, 1H, H-6), 7.14 (td, J¼7.5,
1.1 Hz, 1H, H-8), 7.27e7.33 (m, 2H, H-7, H-9); 13C NMR (101 MHz,
DMSO-d6) d 13.6 (Me), 41.0 (C-9b), 43.6 (MeN), 57.3 (C-3a), 61.3
(C-1), 61.7 (C-3), 62.6 (OCH2), 116.6 (C-6), 119.4 (C-9a), 125.1 (C-8),
129.2 (C-7), 129.3 (C-9), 149.5 (C-5a), 162.8 (CO2H), 164.9 (CO2Et),
167.7 (C-4). Anal. Calcd for C15H17NO4 (CO2H)2: C, 55.89; H, 5.24; N,
3.83. Found: C, 55.94; H, 5.21; N, 3.76.
4.2.4. (3aS*,9bR*)-N,N,2-Trimethyl-4-oxo-1,2,3,3a,4,9b-hexahy-
drochromeno[3,4-c]pyrrole-3a-carboxamide (5d). Yield 87%, a col-
ourless powder, mp 96e98 C (diethyl ether); 1H NMR (400 MHz,
CDCl3) d 2.38 (s, 3H, Me), 2.56 (dd, J¼9.0, 7.1 Hz, 1H, H-10), 2.95 (s,
6H, 2Me), 3.15 (d, J¼10.2 Hz,1H, H-30), 3.21 (dd, J¼9.0, 7.3 Hz,1H, H-
100), 3.80 (t, J¼7.2 Hz, 1H, H-9b), 3.82 (d, J¼10.2 Hz, 1H, H-300), 7.06
(d, J¼8.1 Hz,1H, H-6), 7.15 (td, J¼7.5, 1.0 Hz,1H, H-8), 7.21 (dd, J¼7.5,
1.6 Hz, 1H, H-9), 7.24e7.29 (m,1H, H-7). Anal. Calcd for C15H18N2O3:
C, 65.68; H, 6.61; N, 10.21. Found: C, 65.28; H, 6.69; N, 10.17.
4.2.5. Diethyl ((3aR*,9bS*)-2-methyl-4-oxo-1,2,3,3a,4,9b-hexahy-
drochromeno[3,4-c]pyrrol-3a-yl)phosphonate (5e). Yield 92%, col-
ourless crystals, mp 126e128 C; IR: 3017, 2905, 2844, 2789, 2766,
2755, 1755, 1492, 1456, 1391, 1339, 1148, 1014, 960, 759, 567 cm1;
1H NMR (400 MHz, CDCl3) d 0.92 (t, J¼7.1 Hz, 3H, Me), 1.32
(t, J¼7.1 Hz, 3H, Me), 2.38 (s, 3H, NMe), 2.75 (dd, J¼9.3, 7.6 Hz, 1H,
H-10), 3.04 (t, J¼9.2 Hz, 1H, H-100), 3.21 (t, J¼10.0 Hz, 1H, H-30), 3.64
(dd, J¼10.0, 4.2 Hz, 1H, H-300), 3.72 (ddq, J¼10.0, 8.6, 7.1 Hz, 1H,
OCHH), 3.89 (dp, J¼10.0, 7.0 Hz, 1H, OCHH), 4.05e4.15 (m, 1H,
H-9b), 4.15 (dq, J¼8.2, 7.1 Hz, 2H, OCH2), 7.03 (dd, J¼8.1, 1.1 Hz, 1H,
H-6), 7.10 (td, J¼7.5, 1.1 Hz, 1H, H-8), 7.19 (dd, J¼7.5, 1.5 Hz, 1H, H-9),
7.25 (ddd, J¼8.1, 7.5, 1.5 Hz, 1H, H-8); 13C NMR (101 MHz, CDCl3)
d 16.0 (d, J¼5.8 Hz), 16.5 (d, J¼6.1 Hz), 41.9, 42.3, 52.8
(d, J¼140.1 Hz), 62.4, 63.1 (d, J¼11.1 Hz), 63.5 (d, J¼7.1 Hz), 63.9(d, J¼7.1 Hz), 116.8, 121.5, 124.8, 128.7, 128.9, 150.5, 166.4 (CO); 31P
NMR (162 MHz, CDCl3) d 21.31 (s); HRMS (ESI) calcd for
(C16H22NNaO5P)þ [MþNa]þ: 362.1128, found: 362.1149.
4.3. General procedure for the synthesis of tetrahydro-2H-
spiro[chromeno[3,4-c]pyrrole-1,10-cyclohexanes] 7
A stirred mixture of the corresponding coumarin 4 (1.0 mmol),
cyclohexanone (0.10 g, 1.0 mmol), ﬁnely ground sarcosine (0.27 g,
3.0 mmol) was reﬂuxed in dry toluene (3.3 mL) with removal of the
water formed bymeans of a DeaneStark trap. Reﬂuxwas continued
for 48 h. The resulting mixture was cooled to room temperature
followed by acidiﬁcation with dilute HCl (5 equiv). The cycloaddi-
tion products 7c,e were obtained from the aqueous layer by neu-
tralization with NaHCO3 and subsequent ﬂash chromatography on
silica gel using CH2Cl2:EtOAc as an eluent.
4.3.1. (3aS*,9bR*)-Ethyl 2-methyl-4-oxo-3,3a,4,9b-tetrahydro-2H-
spiro[chromeno[3,4-c]pyrrole-1,10-cyclohexane]-3a-carboxylate
(7c). Yield 17%, a brownish powder, mp 87e91 C; 1H NMR
(400 MHz, CDCl3) d 0.66e0.77 (m, 1H), 1.04 (td, J¼7.1, 0.9 Hz, 3H,
Me), 1.01e1.07 (m, 1H), 1.12e1.21 (m, 1H), 1.21e1.29 (m, 1H),
1.40e1.52 (m, 2H), 1.52e1.62 (m, 3H), 1.77e1.87 (m,1H), 2.49 (s, 3H,
Me), 3.38 (s, 1H, H-9b), 3.55 (d, J¼12.6 Hz, 1H, H-3), 3.93
(d, J¼12.6 Hz, 1H, H-30), 3.99e4.12 (m, 2H, OCH2), 7.10 (d, J¼8.2 Hz,
1H, H-6), 7.12e7.19 (m, 2H, H-8, H-9), 7.29 (t, J¼7.5 Hz, 1H, H-7); 13C
NMR (101 MHz, CDCl3) d 13.9, 21.4, 22.7, 25.4, 29.1, 31.8, 38.3, 54.2,
58.1, 62.6, 63.0, 70.4, 117.0, 119.6, 124.4, 128.8, 129.7, 151.3, 168.0,
171.1; HRMS (ESI) calcd for (C20H26NO4)þ [MþH]þ: 344.1856,
found: 344.1870.
4.3.2. Diethyl ((3aR*,9bS*)-2-methyl-4-oxo-3,3a,4,9b-tetrahydro-
2H-spiro[chromeno[3,4-c]pyrrole-1,10-cyclohexan]-3a-yl)phospho-
nate (7e). Yield 14%, a yellow powder, mp 127e132 C; IR: 2977,
2929, 2860, 2799, 1749, 1689, 1594, 1443, 1260, 1247, 1212, 1035,
577 cm1; 1H NMR (400 MHz, CDCl3) d 0.65e0.75 (m, 1H), 0.82
(td, J¼7.1, 0.4 Hz, 3H, Me), 0.95e1.07 (m,1H), 1.15e1.27 (m, 2H), 1.32
(td, J¼7.1, 0.3 Hz, 3H, Me),1.42e1.65 (m, 5H),1.78e1.87 (m,1H), 2.48
(s, 3H, Me), 3.51 (d, J¼13.0 Hz, 1H, H-3), 3.56 (d, J¼17.4 Hz, 1H,
H-9b), 3.51e3.62 (m, 1H, OCH2), 3.80 (dq, J¼10.0, 7.0 Hz, 1H, OCH2),
3.96 (dd, J¼13.0, 9.9 Hz, 1H, H-30), 4.15 (dq, J¼8.2, 7.1 Hz, 2H, OCH2),
7.06 (dd, J¼8.1, 1.2 Hz, 1H, H-6), 7.13 (td, J¼7.5, 1.2 Hz, 1H, H-8), 7.22
(dd, J¼7.5, 1.7 Hz, 1H, H-9), 7.26e7.31 (m, 1H, H-7); 13C NMR
(101 MHz, CDCl3) d 15.9 (d, J¼6.5 Hz), 16.5 (d, J¼6.0 Hz), 21.2, 22.8,
25.5, 29.0, 31.4, 38.8, 51.3 (d, J¼133.9 Hz), 61.5, 63.4 (d, J¼7.9 Hz),
64.0 (d, J¼7.7 Hz), 77.4, 116.6, 124.3, 128.6, 129.6, 151.7, 167.8; 31P
NMR (162 MHz, CDCl3) d 24.09 (s); (ESI) calcd for (C21H31NO5P)þ
[MþH]þ: 408.1934, found: 408.1938.
4.4. General procedure for the synthesis of pyrrolizidines
8e11 and indolizidines 12e15
A stirred mixture of the corresponding coumarin 4 (1.0 mmol),
paraformaldehyde (0.05 g, 1.7 mmol) and ﬁnely ground proline
(0.13 g, 1.1 mmol) or pipecolinic acid (0.14 g, 1.1 mmol) was reﬂuxed
in dry benzene (8 mL) with removal of the water formed by means
of a DeaneStark trap. After 4e8 h the resulting solution was
evaporated in vacuo to give a crude mixture of products. They were
isolated by column chromatography on silica gel using CH2Cl2:E-
tOAc as eluent. Alternatively, major diastereomers were puriﬁed by
crystallization of the crude mixture of oxalates from acetone or
ethanolewater.
4.4.1. (6aS*,6bR*,11aR*)-Ethyl 6-oxo-6,6a,6b,7,8,9,11,11a-octahy-
drochromeno[3,4-a]pyrrolizine-6a-carboxylate (8c). Yield 47%,
a yellowish oil; IR (the oxalate): 2978, 2764, 2654, 1775, 1743, 1462,
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e589258901342, 1227, 1155, 1030, 1003, 764, 704 cm1; 1H NMR (400 MHz,
CDCl3) (free base) d 1.19 (t, J¼7.1 Hz, 3H, Me), 1.55 (dddd, J¼11.9,11.1,
9.1, 6.9 Hz, 1H, CHH), 1.81 (ddq, J¼12.3, 11.0, 6.5 Hz, 1H, CHH),
1.89e1.96 (m, 1H, CHH), 1.96e2.04 (m, 1H, CHH), 2.65 (ddd, J¼10.6,
9.0, 5.6 Hz, 1H, H-90), 2.81 (t, J¼12.3 Hz, 1H, H-110), 3.13 (dd, J¼12.5,
7.2 Hz, 1H, H-1100), 3.29 (ddd, J¼9.0, 6.7, 1.7 Hz, 1H, H-900), 3.82 (dd,
J¼12.1, 7.2 Hz, 1H, H-11a), 4.09 (dq, J¼10.8, 7.1 Hz, 1H, OCHH), 4.18
(dq, J¼10.8, 7.1 Hz,1H, OCHH), 4.63 (dd, J¼9.1, 7.0 Hz,1H, H-6b), 7.05
(dd, J¼8.5, 1.1 Hz,1H, H-4), 7.12 (td, J¼7.5, 1.1 Hz,1H, H-2), 7.24e7.29
(m, 2H, H-1, H-3); 1H NMR (400MHz, DMSO-d6) (the oxalate) d 1.07
(t, J¼7.1 Hz, 3H, Me),1.60e1.80 (m, 2H, CH2), 1.96e2.11 (m, 2H, CH2),
2.91 (t, J¼12.3 Hz, 1H, H-110), 2.99 (td, J¼10.6, 5.7 Hz, 1H, H-90), 3.44
(dd, J¼12.3, 7.4 Hz, 1H, H-1100), 3.43e3.48 (m, 1H, H-900), 4.08 (dq,
J¼10.8, 7.1 Hz, 1H, OCHH), 4.14 (dq, J¼10.8, 7.1 Hz, 1H, OCHH), 4.21
(dd, J¼12.3, 7.4 Hz,1H, H-11a), 4.67 (dd, J¼9.4, 7.2 Hz,1H, H-6b), 7.17
(d, J¼8.2 Hz, 1H, H-4), 7.22 (td, J¼7.5, 1.1 Hz,1H, H-2), 7.37 (td, J¼7.9,
1.6 Hz,1H, H-3), 7.47 (dd, J¼7.5, 1.6 Hz,1H, H-1); 13C NMR (101MHz,
DMSO-d6) (the oxalate) d 13.7, 25.5, 28.0, 40.0, 55.9, 60.3, 62.9, 69.6,
116.6, 118.8, 125.2, 129.5, 129.6, 150.0, 163.4 (CO), 163.6 (CO), 164.8
(CO). Anal. Calcd for C17H19NO4$(CO2H)2: C, 58.31; H, 5.41; N, 3.58.
Found: C, 58.34; H, 5.40; N, 3.32.
4.4.2. (6aS*,11aR*,11bR*)-Ethyl 6-oxo-6,6a,7,9,10,11,11a,11b-octahy-
drochromeno[4,3-a]pyrrolizine-6a-carboxylate (9c). Yield 11%, a yel-
lowish oil; 1H NMR (400 MHz, CDCl3) d 0.90e1.02 (m, 1H), 1.06
(t, J¼7.1 Hz, 3H, Me),1.37e1.47 (m,1H),1.56e1.69 (m,1H),1.70e1.78
(m, 1H), 2.70 (td, J¼10.0, 6.0 Hz, 1H, H-90), 3.23 (ddd, J¼9.4, 7.0,
2.3 Hz, 1H, H-900), 3.66 (d, J¼12.4 Hz, 1H, H-70), 4.01 (d, J¼12.4 Hz,
1H, H-700), 4.03 (d, J¼9.7 Hz, 1H, H-11b), 3.95e4.04 (m, 1H, H-11a),
4.03e4.16 (m, 2H, OCH2), 7.10 (dd, J¼8.2, 1.1 Hz, 1H, H-4), 7.14 (td,
J¼7.4, 1.1 Hz, 1H, H-2), 7.19 (dd, J¼7.6, 1.8 Hz, 1H, H-1), 7.29 (ddd,
J¼8.2, 7.2, 1.8 Hz, 1H, H-3); HRMS (ESI) calcd for (C17H20NO4)þ
[MþH]þ: 302.1387, found: 302.1383.
4.4.3. (6aS*,11aS*,11bR*)-Ethyl 6-oxo-6,6a,7,9,10,11,11a,11b-octahy-
drochromeno[4,3-a]pyrrolizine-6a-carboxylate (10c). Yield 10%,
a yellow oil; 1H NMR (400 MHz, CDCl3) d 1.03 (t, J¼7.1 Hz, 3H, Me),
1.82e2.04 (m, 4H, 2CH2), 2.73e2.80 (m, 1H, H-90), 3.03e3.09 (m,
1H, H-900), 3.25e3.29 (m, 2H, H-7), 3.35 (ddd, J¼10.2, 6.7, 3.7 Hz, 1H,
H-11a), 4.03 (dq, J¼10.8, 7.1 Hz, 1H, OCHH), 4.08 (dq, J¼10.8, 7.1 Hz,
1H, OCHH), 4.17 (d, J¼10.2 Hz, 1H, H-11b), 7.11 (dt, J¼7.6, 1.2 Hz, 1H,
H-2), 7.11 (dd, J¼8.2,1.2 Hz,1H, H-4), 7.17 (dd, J¼7.6,1.8 Hz,1H, H-1),
7.30 (ddd, J¼8.2, 7.3, 1.8 Hz, 1H, H-3); HRMS (ESI) calcd for
(C17H20NO4)þ [MþH]þ: 302.1387, found: 302.1378.
4.4.4. (6aS*,6bR*,11aR*)-N,N-Dimethyl-6-oxo-6,6a,6b,7,8,9,11,11a-
octahydrochromeno[3,4-a]pyrrolizine-6a-carboxamide oxalate
(8d). Yield 60%, a pale yellow powder, mp 147e152 C (ethanol). IR:
3017, 2529, 1755, 1712, 1646, 1177, 1150, 762, 712, 687 cm1; 1H
NMR (400 MHz, DMSO-d6þCCl4) d 1.47e1.58 (m, 1H, H-70),
1.81e1.93 (m, 1H, H-80), 2.00e2.09 (m, 1H, H-700), 2.13e2.21 (m, 1H,
H-800), 2.81 (s, 3H, MeN), 2.95 (t, J¼13.0 Hz, 1H, H-110), 3.09 (s, 3H,
MeN), 3.09e3.15 (m, 1H, H-90), 3.45 (dd, J¼12.4, 7.0 Hz, 1H, H-1100),
3.63 (dd, J¼9.7, 7.0 Hz,1H, H-900), 4.38 (dd, J¼13.4, 7.0 Hz,1H, H-11a),
4.94 (dd, J¼10.4, 7.5 Hz,1H, H-6b), 7.01 (d, J¼8.2 Hz,1H, H-4), 7.15 (t,
J¼7.5 Hz, 1H, H-2), 7.28 (td, J¼7.8, 1.3 Hz, 1H, H-3), 7.43 (d, J¼7.5 Hz,
1H, H-1); 13C NMR (101MHz, DMSO-d6) d 25.3 (C-8), 27.8 (C-7), 37.0
(MeN), 37.1 (MeN), 41.3 (C-11a), 54.1 (C-9), 55.8 (C-11), 60.4 (C-6a),
68.0 (C-6b), 116.1 (C-4), 119.7 (C-11b), 125.0 (C-2), 129.2 (C-3), 129.4
(C-1), 150.2 (C-4a), 161.1 (CO), 163.6 (CO2H), 164.4 (C-6). Anal. Calcd
for C17H20N2O3$(CO2H)2: C, 58.46; H, 5.68; N, 7.18. Found: C, 58.50;
H, 6.04; N, 6.87.
4.4.5. Diethyl ((6aR*,6bR*,11aS*)-6-oxo-6,6a,6b,7,8,9,11,11a-octahy-
drochromeno[3,4-a]pyrrolizin-6a-yl)phosphonate oxalate (8e). Yield
44%, white crystals, mp 133e136 C (ethanol); IR: 2979, 2931, 2637,1756, 1716, 1644, 1338, 1254, 1156, 1035, 1013, 772, 703 cm1; 1H
NMR (400 MHz, DMSO-d6) d 0.85 (t, J¼7.1 Hz, 3H, Me), 1.21 (t,
J¼7.1 Hz, 3H, Me), 1.71e1.84 (m, 1H, CHH), 2.00e2.09 (m, 1H, CHH),
2.14e2.24 (m, 2H, CH2), 2.93 (t, J¼12.2 Hz, 1H, H-110), 3.01 (td,
J¼11.1, 5.9 Hz, 1H, H-90), 3.29 (tq, J¼10.0, 7.0 Hz, 1H, OCHH),
3.45e3.53 (m, 2H, H-900, H-1100), 3.70 (dquint, J¼10.1, 7.1 Hz, 1H,
OCHH), 3.97e4.12 (m, 2H, OCH2), 4.17 (td, J¼12.1, 7.6 Hz, 1H, H-11a),
4.63 (t, J¼8.2 Hz, 1H, H-6b), 7.19 (dd, J¼8.2, 1.0 Hz, 1H, H-4), 7.24 (td,
J¼7.5, 1.0 Hz, 1H, H-2), 7.42 (td, J¼7.9, 1.5 Hz, 1H, H-3), 7.47 (dd,
J¼7.5, 1.5 Hz,1H, H-1); 31P NMR (162MHz, DMSO-d6) d 17.62 (s); 31P
NMR (162 MHz, CDCl3þCCl4) (free base) d 19.97 (s); HRMS (ESI, free
base) calcd for (C18H25NO5P)þ [MþH]þ: 366.1465, found: 366.1462.
4.4.6. Diethyl ((6aR*,11aR*,11bS*)-6-oxo-6,6a,7,9,10,11,11a,11b-octa-
hydrochromeno[4,3-a]pyrrolizin-6a-yl)phosphonate (9e). Yield 12%,
amorphous paste; 1H NMR (400 MHz, CDCl3) d 0.90 (td, J¼7.1,
0.5 Hz, 3H, Me), 1.33 (td, J¼7.1, 0.5 Hz, 3H, Me), 0.93e1.02 (m,1H, H-
110), 1.39e1.47 (m, 1H, H-1100), 1.56e1.67 (m, 1H, H-100), 1.67e1.75
(m, 1H, H-1000), 2.66 (td, J¼10.0, 5.9 Hz, 1H, H-90), 3.21 (ddd, J¼9.2,
6.7, 2.1 Hz, 1H, H-900), 3.57 (ddq, J¼10.0, 8.9, 7.1 Hz, 1H, OCHH), 3.63
(dd, J¼12.4, 10.0 Hz, 1H, H-70), 3.83 (dquint, J¼10.0, 7.1 Hz, 1H,
OCHH), 3.95 (td, J¼9.4, 7.2 Hz, 1H, H-11a), 3.99 (dd, J¼12.4, 1.1 Hz,
1H, H-700), 4.08e4.17 (m, 2H, OCH2), 4.10e4.18 (m, 1H, H-11b), 7.06
(dd, J¼8.1, 1.2 Hz, 1H, H-4), 7.13 (td, J¼7.5, 1.2 Hz, 1H, H-2), 7.23 (dd,
J¼7.6, 1.8 Hz, 1H, H-1), 7.28 (ddd, J¼8.1, 7.5, 1.8 Hz, 1H, H-3); 31P
NMR (162 MHz, CDCl3) d 20.96 (s); HRMS (ESI) calcd for
(C18H24NNaO5P)þ [MþNa]þ: 388.1284, found: 388.1283.
4.4.7. (6aS*,6bR*,11aR*)-6a-Benzoyl-6b,7,8,9,11,11a-hexahy-
drochromeno[3,4-a]pyrrolizin-6(6aH)-one oxalate (8f). Yield 50%,
pale yellow crystals, mp 144e147 C (acetone); 1H NMR (400 MHz,
DMSO-d6) d 1.30e1.42 (m, 1H), 1.69e1.83 (m, 1H), 1.85e2.00 (m,
2H), 3.00e3.12 (m, 2H, NCH2), 3.54 (dd, J¼12.4, 7.2 Hz, 1H, NCHH),
3.52e3.60 (m, 1H, NCHH), 4.48 (dd, J¼12.6, 6.9 Hz, 1H, H-11a), 5.33
(dd, J¼9.5, 7.5 Hz, 1H, H-6b), 7.06 (d, J¼8.0 Hz, 1H, H-4), 7.25
(t, J¼7.4 Hz, 1H, H-2), 7.30e7.37 (m, 1H), 7.53e7.58 (m, 3H), 7.71
(d, J¼7.4 Hz, 1H), 7.95 (d, J¼7.8 Hz, 2H). Anal. Calcd for
C21H19NO3$(CO2H)2$0.75H2O: C, 63.22; H, 5.19; N, 3.21. Found: C,
63.24; H, 4.96; N, 3.25.
4.4.8. (6aS*,6bS*,11aR*)-6a-Methyl-6b,7,8,9,11,11a-hexahy-
drochromeno[3,4-a]pyrrolizin-6(6aH)-one hydrochloride (11g).
Yield 41%, a white powder, mp 187e192 C; 1H NMR (400 MHz,
CDCl3, the free base) d 1.49 (s, 3H, Me), 1.68e1.81 (m, 2H, CH2),
1.90e1.98 (m, 2H, CH2), 2.41 (ddd, J¼9.9, 8.4, 6.7 Hz, 1H, H-90), 2.97
(dd, J¼11.0, 7.1 Hz,1H, H-110), 3.01 (ddd, J¼9.9, 6.9, 3.7 Hz,1H, H-900),
3.31 (t, J¼6.9 Hz, 1H), 3.56e3.62 (m, 2H), 7.03 (d, J¼8.3 Hz, 1H, H-4),
7.11 (td, J¼7.6, 1.2 Hz, 1H, H-2), 7.22e7.28 (m, 2H, H-1, H-3). Anal.
Calcd for C15H17NO2$HCl: C, 64.40; H, 6.49; N, 5.01. Found: C, 64.56;
H, 4.74; N, 4.98.
4.4.9. Diethyl ((6aR*,6bS*,12aS*)-6-oxo-6a,6b,7,8,9,10,12,12a-octahy-
dro-6H-chromeno[3,4-a]indolizin-6a-yl)phosphonate (12) and di-
ethyl ((6aR*,6bR*,12aS*)-6-oxo-6a,6b,7,8,9,10,12,12a-octahydro-6H-
chromeno[3,4-a]indolizin-6a-yl)phosphonate (13). Yield 51%,
a white powder, mp 144e148 C; IR: 2963, 2931, 2853, 1755, 1243,
1212, 1143, 1015, 795, 697 cm1; 1H NMR (400 MHz, CDCl3) (12,
39%) d 0.90 (t, J¼7.1 Hz, 3H, Me), 1.29 (t, J¼7.1 Hz, 3H, Me), 1.15e2.29
(m, 6H, 3CH2), 2.05e2.16 (m, 1H, H-100), 2.17e2.27 (m, 1H, H-120),
2.75 (ddd, J¼20.7, 11.4, 2.4 Hz, 1H, H-6b), 3.08e3.15 (m, 1H, H-1000),
3.44 (t, J¼8.0 Hz, 1H, H-1200), 3.69e4.24 (m, 5H, 2CH2O, H-12a), 7.02
(dd, J¼8.1, 1.0 Hz,1H, H-4), 7.09 (td, J¼7.4, 1.0 Hz,1H, H-2), 7.14e7.26
(m, 2H, H-1, H-3); 31P NMR (162 MHz, CDCl3) d 20.73 (s); 1H NMR
(400 MHz, CDCl3) (13, 61%) d 1.03 (t, J¼7.1 Hz, 3H, Me), 1.33 (t,
J¼7.1 Hz, 3H, Me), 1.15e2.29 (m, 6H, 3CH2), 2.00 (td, J¼11.7, 3.0 Hz,
1H, H-100), 2.63 (td, J¼10.9, 2.5 Hz, 1H, H-6b), 2.84 (t, J¼9.2 Hz, 1H,
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e5892 5891H-120), 2.97e3.03 (m,1H, H-1000), 3.04 (dd, J¼9.0, 3.5 Hz,1H, H-1200),
3.69e4.24 (m, 5H, 2CH2O, H-12a), 6.98 (dd, J¼8.1, 1.0 Hz, 1H, H-4),
7.08 (td, J¼7.5, 1.0 Hz, 1H, H-2), 7.14e7.26 (m, 2H, H-1, H-3); 31P
NMR (162 MHz, CDCl3) d 23.01 (s); HRMS (ESI) calcd for
(C19H27NO5P)þ [MþH]þ: 380.1621, found: 380.1626.
4.4.10. Diethyl ((6aR*,12aR*,12bS*)-6-oxo-6a,7,9,10,11,12,12a,12b-oc-
tahydro-6H-chromeno[4,3-a]indolizin-6a-yl)phosphonate (14). Yield
12%, a colourless oil; 1H NMR (400 MHz, CDCl3) d 0.90 (t, J¼7.0 Hz,
3H, Me),1.13e1.27 (m, 2H),1.33 (td, J¼7.0, 0.4 Hz, 3H, Me),1.32e1.40
(m, 2H), 1.44e1.52 (m, 1H), 1.63e1.72 (m, 1H), 2.11 (td, J¼11.6,
2.5 Hz, 1H, H-90), 2.45 (t, J¼10.5 Hz, 1H, H-12a), 2.78 (dd, J¼8.0,
6.8 Hz,1H, H-70), 2.97e3.05 (m,1H, H-900), 3.71e3.83 (m,1H, OCHH),
3.80 (d, J¼8.4 Hz, 1H, H-700), 3.83e3.93 (m, 1H, OCHH), 4.13 (dd,
J¼18.5, 10.0 Hz, 1H, H-12b), 4.17 (dq, J¼8.2, 7.1 Hz, 2H, OCH2), 6.99
(d, J¼8.0 Hz, 1H, H-4), 7.06e7.11 (m, 2H, ArH), 7.20e7.25 (m, 1H,
ArH); 13C NMR (101 MHz, CDCl3) d 15.9 (d, J¼6.4 Hz), 16.5 (d,
J¼6.0 Hz), 24.3, 24.5, 28.1, 44.7, 51.8, 52.1 (d, J¼140.5 Hz), 61.1, 63.2
(d, J¼7.2 Hz), 63.4 (d, J¼7.1 Hz), 67.1 (d, J¼9.0 Hz), 116.5, 119.6, 124.2,
128.6, 129.9, 150.9, 166.5; 31P NMR (162 MHz, CDCl3) d 22.14 (s);
HRMS (ESI) calcd for (C19H27NO5P)þ [MþH]þ: 380.1621, found:
380.1640.
4.4.11. Diethyl ((6aR*,12aS*,12bS*)-6-oxo-6a,7,9,10,11,12,12a,12b-oc-
tahydro-6H-chromeno[4,3-a]indolizin-6a-yl)phosphonate (15). Yield
9%, an amorphous paste; 1H NMR (400 MHz, CDCl3) d 0.90 (t,
J¼7.1 Hz, 3H, Me), 1.00e1.14 (m, 1H), 1.29 (t, J¼7.0 Hz, 3H, Me),
1.32e1.44 (m, 1H), 1.54e1.64 (m, 2H), 1.73e1.84 (m, 2H), 1.88
(t, J¼10.5 Hz,1H, H-12a), 2.00e2.10 (m,1H, H-90), 3.02e3.09 (m,1H,
H-900), 3.19 (t, J¼11.2 Hz, 1H, H-70), 3.45 (dd, J¼18.3, 10.3 Hz, 1H,
H-12b), 3.68e3.80 (m, 1H, OCHH), 3.85e3.96 (m, 2H, OCHH, H-700),
4.16 (dq, J¼8.2, 7.1 Hz, 2H, OCH2), 7.04 (dd, J¼8.2, 1.0 Hz, 1H, H-4),
7.11 (td, J¼7.5, 1.0 Hz, 1H, H-2), 7.19 (dd, J¼7.5, 1.6 Hz, 1H, H-4),
7.24e7.30 (m, 1H, H-3); 13C NMR (101 MHz, CDCl3) d 15.9
(d, J¼6.2 Hz), 16.5 (d, J¼5.7 Hz), 23.4, 25.1, 28.7, 48.6, 49.7
(d, J¼139.5 Hz), 52.2, 63.4 (d, J¼7.0 Hz), 64.0 (d, J¼7.1 Hz), 68.6
(d, J¼11.9 Hz), 116.6, 119.3, 124.5, 128.9, 129.3, 150.5, 167.5; 31P NMR
(162 MHz, CDCl3) d 22.37 (s); HRMS (ESI) calcd for
(C19H26NNaO5P)þ [MþNa]þ: 402.1441, found: 402.1447.
4.5. General procedure for the synthesis of 11-
phenyloctahydrochromeno[3,4-a]pyrrolizines 16e17
A mixture of the corresponding coumarin 4 (1.0 mmol), benz-
aldehyde (0.04 g, 0.4 mmol) and ﬁnely ground proline (0.12 g,
1.0 mmol) was reﬂuxed in dry toluene (8 mL) with magnetic stir-
ring and removal of the water formed by means of a DeaneStark
trap. After 3 h, a second portion of benzaldehyde (0.04 g, 0.4 mmol)
was added; after another 2 h, a third portion of benzaldehyde
(0.04 g, 0.4 mmol) was added. Reﬂux was continued for an addi-
tional 4 h. Adducts 16 and 17 were isolated by column chroma-
tography on silica gel using CH2Cl2:EtOAc as an eluent.
Alternatively, for 17c: the crude yellow reactionmixturewas cooled
to room temperature and slowly ﬁltered through a thin layer of
silica gel, thenwashed with toluene. Isopropanol (0.07 g, 1.2 mmol)
and acetyl chloride (0.09 g, 1.1 mmol) were added with stirring to
the solution, the resulting mixture was allowed to stand overnight
at room temperature. The formed dark-magenta precipitate was
dissolved in hot acetone, diluted with EtOAc and then kept for 2
days in a refrigerator. The colourless crystals of the product were
ﬁltered and washed with an acetoneeethyl acetate mixture. The
hydrochloride of adduct 17c was dried to a constant weight.
4.5.1. (6aS*,6bS*,11R*,11aR*)-Ethyl 6-oxo-11-phenyl-6,6a,6b,7,8,9,11,
11a-octahydrochromeno[3,4-a]pyrrolizine-6a-carboxylate (16c) and
(6aS*,6bR*,11S*,11aR*)-ethyl 6-oxo-11-phenyl-6,6a,6b,7,8,9,11,11a-octahydrochromeno[3,4-a]pyrrolizine-6a-carboxylate (17c). Yield 37%,
a yellowish powder, mp 80e120 C; 1H NMR (400 MHz, CDCl3) (16c,
36%) d 1.04 (t, J¼7.1 Hz, 3H, Me), 1.60e2.13 (m, 4H), 2.45e2.57 (m,
1H), 2.91e2.97 (m,1H), 3.60 (d, J¼10.6 Hz,1H, CH), 3.73 (d, J¼10.6 Hz,
1H, CH), 4.01e4.22 (m, 2H, OCH2), 4.63 (t, J¼7.4 Hz, 1H, H-6b), 6.37
(dd, J¼7.5,1.5 Hz,1H, H-1), 6.62e7.47 (m, 8H, Ar); 1H NMR (400MHz,
CDCl3) (17c, 64%) d 1.17 (t, J¼7.1 Hz, 3H, Me), 1.60e1.71 (m, 1H),
1.85e2.13 (m, 3H), 2.87 (td, J¼9.6, 6.0 Hz, 1H, H-90), 3.35 (ddd, J¼9.6,
6.9, 2.7 Hz, 1H, H-900), 4.01e4.22 (m, 2H, OCH2), 4.31 (d, J¼8.7 Hz,1H,
CH), 4.39 (d, J¼8.7 Hz, 1H, CH), 4.83 (dd, J¼9.6, 6.8 Hz, 1H, H-6b),
6.82e7.36 (m, 9H, Ar); HRMS (ESI) calcd for (C23H24NO4)þ [MþH]þ:
378.1700, found: 378.1700.
4.5.2. (6aS*,6bR*,11S*,11aR*)-Ethyl 6-oxo-11-phenyl-6,6a,6b,7,8,9,11,
11a-octahydrochromeno[3,4-a]pyrrolizine-6a-carboxylate hydro-
chloride (17c). Yield 0.49 g (26%), colourless crystals, mp
162e167 C; IR: 2323,1766,1731,1239,1154, 756, 734, 699 cm1; 1H
NMR (400MHz, DMSO-d6) d 1.16 (t, J¼7.1 Hz, 3H,Me),1.94 (br s,1H),
2.19 (br s, 2H), 2.42 (br s, 1H), 3.60 (br s, 1H), 3.98 (br s, 1H), 4.15
(ABX3-system, J¼7.1, 10.8 Hz, 2H, OCH2), 4.94 (br s, 1H), 5.42 (br s,
2H), 6.67 (dd, J¼7.6, 1.6 Hz, 1H, H-1), 6.91 (d, J¼7.6 Hz, 2H, Ph), 7.05
(t, J¼7.5 Hz, 2H, Ph), 7.14 (t, J¼7.4 Hz, 1H, Ph), 7.17e7.24 (m, 2H, H-2,
H-4), 7.61 (d, J¼7.0 Hz, 1H, H-4). Anal. Calcd for C23H23NO4$HCl: C,
66.74; H, 5.84; N, 3.38. Found: C, 66.68; H, 6.00; N, 3.37.
4.5.3. Diethyl ((6aR*,6bS*,11R*,11aS*)-6-oxo-11-phenyl-6,6a,6b,7,8,9,
11,11a-octahydrochromeno[3,4-a]pyrrolizin-6a-yl)phosphonate
(16e). Yield 33%, an amorphous paste; 1H NMR (400 MHz, CDCl3)
d 0.88 (t, J¼7.1 Hz, 3H, Me), 1.32 (td, J¼7.0, 0.4 Hz, 3H, Me),
1.82e2.00 (m, 2H), 2.02e2.14 (m, 1H), 2.48 (dt, J¼10.2, 7.1 Hz, 1H),
2.74e2.83 (m, 1H), 2.83e2.93 (m, 1H), 3.49e3.59 (m, 1H, OCHH),
3.54 (dd, J¼10.7, 1.7 Hz, 1H, H-11), 3.76e3.86 (m, 1H, OCHH), 3.90
(dd, J¼14.4, 10.7 Hz, 1H, H-11a), 4.15 (dq, J¼8.1, 7.1 Hz, 2H, OCH2),
4.53 (dt, J¼13.2, 7.0 Hz, 1H, H-6b), 6.40 (dd, J¼7.5, 1.6 Hz, 1H, H-1),
6.87 (td, J¼7.5, 1.1 Hz, 1H, H-2), 7.05 (dd, J¼8.1, 1.1 Hz, 1H, H-4),
7.14e7.20 (m, 2H, Ph), 7.23 (ddd, J¼8.1, 7.7, 1.6 Hz, 1H, H-3),
7.25e7.29 (m, 3H, Ph); 31P NMR (162 MHz, CDCl3) d 21.31 (s); 13C
NMR (101 MHz, CDCl3) d 16.0 (d, J¼5.8 Hz), 16.5 (d, J¼6.3 Hz), 26.6,
27.8 (d, J¼1.9 Hz), 53.0, 53.7 (d, J¼138.0 Hz), 54.3, 63.5 (d, J¼8.8 Hz),
63.9 (d, J¼7.8 Hz), 71.0, 76.5 (d, J¼14.6 Hz), 116.2, 120.0, 124.1, 128.0,
128.4, 128.9, 129.0, 150.8, 164.9; HRMS (ESI) calcd for
(C24H29NO5P)þ [MþH]þ: 442.1778, found: 442.1777.
4.5.4. Diethyl ((6aR*,6bR*,11S*,11aS*)-6-oxo-11-phenyl-6,6a,6b,7,8,9,
11,11a-octahydrochromeno[3,4-a]pyrrolizin-6a-yl)phosphonate
(17e). Yield 21%, a yellow viscous oil; 1H NMR (400 MHz, CDCl3)
d 0.81 (t, J¼7.1 Hz, 3H, Me),1.34 (td, J¼7.1, 0.3 Hz, 3H, Me),1.82e2.30
(m, 4H, 2CH2), 2.81 (dt, J¼10.4, 7.3 Hz, 1H, H-90), 3.12e3.21 (m, 1H,
H-900), 3.15e3.26 (m,1H, OCHH), 3.61e3.71 (m,1H, OCHH), 4.13 (dq,
J¼8.3, 7.1 Hz, 2H, OCH2), 4.29 (d, J¼9.5 Hz, 1H, H-11), 4.37 (dd,
J¼16.1, 9.5 Hz, 1H, H-11a), 4.56 (ddd, J¼10.2, 6.7, 1.6 Hz, 1H, H-6b),
6.64 (dd, J¼8.1, 1.2 Hz, 1H, H-4), 6.89e6.94 (m, 2H, Ph), 6.96e7.01
(m, 3H, Ph), 7.06 (td, J¼7.8, 1.7 Hz, 1H, H-3), 7.17 (dd, J¼7.5, 1.7 Hz,
1H, H-1), 7.27e7.32 (m,1H, H-2); 31P NMR (162MHz, CDCl3) d 20.43
(s); HRMS (ESI) calcd for (C24H29NO5P)þ [MþH]þ: 442.1778, found:
442.1761.
4.6. Representative reactions of compounds 5
4.6.1. (3aR*,9bS*)-3a-(Diethoxyphosphoryl)-2,2-dimethyl-4-oxo-
1,2,3,3a,4,9b-hexahydrochromeno[3,4-c]pyrrol-2-ium iodide (18).
Methyl iodide (0.43 g, 3.0 mmol) was added to a stirred solution of
the benzopyranopyrrolidine 5e (0.34 g, 1.0 mmol) in anhydrous
toluene (4 mL) at room temperature. The resulting mixture was
stirred for 2 days at room temperature. The white precipitate was
ﬁltered, washedwith anhydrous PhMe, Et2O, and dried. Yield 0.43 g
V.S. Moshkin et al. / Tetrahedron 69 (2013) 5884e58925892(89%), a white powder, mp 187e192 C (decomp.); IR: 2972, 1746,
1496, 1456, 1280, 1254, 1237, 1201, 1033, 1010, 779, 551 cm1; 1H
NMR (400 MHz, DMSO-d6) d 0.85 (t, J¼7.0 Hz, 3H, Me), 1.24 (t,
J¼7.0 Hz, 3H, Me), 3.29 (s, 3H, NMe), 3.34 (s, 3H, NMe), 3.71e3.82
(m, 1H), 3.85e4.00 (m, 2H), 4.04e4.20 (m, 3H), 4.27e4.41 (m, 2H),
4.63 (ddd, J¼19.0, 12.7, 6.9 Hz, 1H, H-9b), 7.22 (d, J¼8.1 Hz, 1H, H-6),
7.27 (t, J¼7.4 Hz, 1H, H-8), 7.45 (t, J¼7.8 Hz, 1H, H-7), 7.57
(d, J¼7.2 Hz, 1H, H-9); 13C NMR (101 MHz, DMSO-d6) d 15.5
(d, J¼6.0 Hz), 16.1 (d, J¼5.7 Hz), 50.3 (d, J¼136.6 Hz), 53.7, 54.3, 64.5
(d, J¼7.1 Hz), 64.7 (d, J¼7.2 Hz), 68.6 (d, J¼11.6 Hz), 69.7, 115.7, 116.7,
125.2, 129.3, 130.1, 150.0, 163.5 (d, J¼3.4 Hz); 31P NMR (162 MHz,
DMSO-d6) d 18.93 (s). Anal. Calcd for C17H25INO5P: C, 42.43; H, 5.24;
N, 2.91. Found: C, 42.41; H, 5.22; N, 2.92.
4.6.2. (3R*,4S*)-Methyl 3-(diethoxyphosphoryl)-4-(2-hydroxy-
phenyl)-1-methylpyrrolidine-3-carboxylate (19). A solution of the
benzopyranopyrrolidine 5e (0.34 g, 1.0 mmol) in methanol (4 mL)
was reﬂuxed for 10 min. The solvent was evaporated in vacuo to
give an oily product. Yield 95%, a yellow viscous oil; 1H NMR
(400 MHz, CDCl3) d 1.33e1.39 (m, 6H, 2Me), 2.51 (s, 3H, NMe), 2.83
(dd, J¼9.5, 6.7 Hz, 1H, H-50), 2.85 (dd, J¼17.1, 10.2 Hz, 1H, H-20), 3.14
(s, 3H, MeO), 3.17 (d, J¼9.5 Hz, 1H, H-500), 3.93 (dd, J¼20.8, 6.7 Hz,
1H, H-4), 4.02 (dd, J¼10.2, 6.0 Hz, 1H, H-200), 4.16e4.24 (m, 4H,
OCH2), 6.66 (t, J¼7.5 Hz, 1H, H-5(Ar)), 6.76 (d, J¼8.0 Hz, 1H, H-
3(Ar)), 6.94 (dd, J¼7.6, 1.5 Hz, 1H, H-6(Ar)), 7.03e7.09 (m, 1H, H-
4(Ar)); 13C NMR (101 MHz, CDCl3) d 16.5 (d, J¼6.2 Hz), 16.6
(d, J¼5.8 Hz), 39.9, 50.7, 52.3, 59.0, 59.8 (d, J¼142.0 Hz), 59.8
(d, J¼2.9 Hz), 62.9 (d, J¼7.4 Hz), 64.0 (d, J¼6.9 Hz),118.0,118.1,129.2,
132.6, 156.7, 168.8 (d, J¼2.0 Hz); 31P NMR (162 MHz, CDCl3) d 25.39
(s); HRMS (ESI) calcd for (C17H27NO6P)þ [MþH]þ: 372.1571, found:
372.1580.
4.6.3. (3aR*,9bS*)-4-Ethoxy-3a-(hydroxymethyl)-2-methyl-
1,2,3,3a,4,9b-hexahydrobenzo[5,6][1,2]oxaphosphinino[3,4-c]pyrrole
4-oxide (20). Sodium borohydride (0.06 g, 1.7 mmol) was added to
a stirred solution of the benzopyranopyrrolidine 5e (0.34 g,
1.0 mmol) in ethanol (4 mL) and the resulting mixture was reﬂuxed
for 1 h. After cooling to room temperature, a solution of NH4Cl
(0.46 g, 8.5 mmol) in water (2 mL) was added. The solvents were
evaporated in vacuo at 50 C, then the residue was treated with
warm ethanol (23 mL). An alcoholic solution was ﬁltered and
evaporated on a rotary evaporator. The crude product was dissolved
in CHCl3 (5 mL), and insoluble salts were ﬁltered off. Evaporation in
vacuo led to a white powder of alcohol 20. Yield 0.29 g (96%), mp
87e91 C; 1H NMR (400 MHz, CDCl3) d 1.21 (t, J¼7.0 Hz, 3H, Me),
2.65 (s, 3H, MeN), 2.85e2.93 (m, 1H, H-10), 3.11 (dd, J¼24.4, 12.0 Hz,
1H, H-30), 3.94e4.06 (m, 3H, H-9b, OCH2), 4.14 (dd, J¼11.7, 2.5 Hz,
1H, OCH2), 4.25 (dd, J¼11.7, 3.6 Hz, 1H, OCH2), 4.34 (t, J¼13.1 Hz, 1H,
H-300), 4.73 (dd, J¼11.0, 7.9 Hz, 1H, H-100), 6.91 (d, J¼8.0 Hz, 1H, H-6),
6.99 (t, J¼7.0 Hz, 1H, H-8), 7.12 (d, J¼7.4 Hz, 1H, H-9), 7.17 (t,
J¼7.7 Hz, 1H, H-7); 13C NMR (101 MHz, CDCl3) d 17.3 (d, J¼6.4 Hz),
39.5 (d, J¼2.7 Hz), 44.7, 47.5 (d, J¼135.0 Hz), 58.2, 61.0 (d, J¼6.4 Hz),
63.6, 65.9 (d, J¼5.2 Hz), 117.9, 122.6, 128.5, 129.3, 154.2; 31P NMR
(162MHz, CDCl3) d 18.71 (s). HRMS (ESI) calcd for (C14H20NNaO4P)þ
[MþNa]þ: 320.1022, found: 320.1035.
4.6.4. (3S*,4R*)-3-Cyano-4-(2-hydroxyphenyl)-1-methylpyrrolidine-
3-carboxylic acid (21). Amino acid 21 was obtained by heating
adduct 5b (0.35 g, 1.5 mmol) inwet chloroform (5 mL) for 10 min at
50 C. Yield 89% (0.33 g), an amorphous paste; 1H NMR (400 MHz,
CDCl3) d 2.52 (s, 3H, Me), 2.75 (dd, J¼9.9, 7.8 Hz, 1H, H-50), 3.16 (d,
J¼9.3 Hz, 1H, H-20), 3.17e3.23 (m, 1H, H-500), 3.61 (dd, J¼7.8, 5.6 Hz,
1H, H-4), 3.64 (d, J¼9.3 Hz, 1H, H-200), 6.76 (td, J¼7.4, 1.1 Hz, 1H,ArH), 6.87 (dd, J¼8.1, 1.1 Hz, 1H, ArH), 7.02 (dd, J¼7.4, 1.6 Hz, 1H,
ArH), 7.17 (ddd, J¼8.1, 7.4, 1.6 Hz, 1H, ArH), 10.6e12.1 (br s, 1H);
HRMS (ESI) calcd for (C13H15N2O3)þ [MþH]þ: 247.1077, found:
247.1082.
4.6.5. ((3S*,4S*)-4-(2-Hydroxyphenyl)-1-methylpyrrolidin-3-yl)(pip-
eridin-1-yl)methanone (22). Piperidine (0.35 g, 4.1 mmol) was
added to a stirred suspension of the oxalate 5a (0.30 g, 1.0 mmol) in
dry benzene (4 mL) and the resulting mixture was reﬂuxed for 1 h.
After cooling to room temperature, the precipitate of piperidinium
oxalate was ﬁltered off. Benzene was evaporated in vacuo. Yield
85%, a yellowish powder, mp 153e155 C; IR: 3060, 2933, 2838,
2507, 1635, 1580, 1486, 1432, 1250, 1208, 753 cm1; 1H NMR
(400 MHz, DMSO-d6) d 0.94e1.03 (m, 1H), 1.12e1.24 (m, 2H),
1.25e1.35 (m, 2H), 1.36e1.46 (m, 1H), 2.36 (s, 3H, MeN), 2.61 (t,
J¼8.9 Hz,1H, H-50), 2.66 (dd, J¼9.0, 5.5 Hz,1H, H-20), 2.77 (dd, J¼9.0,
6.5 Hz, 1H, H-200), 2.72e2.80 (m, 1H, NCH2), 2.97e3.07 (m, 1H,
NCH2), 3.21 (ddd, J¼12.6, 6.8, 3.5 Hz, 1H, NCH2), 3.28 (dd, J¼9.1,
5.5 Hz, 1H, H-500), 3.41 (ddd, J¼13.2, 6.6, 2.8 Hz, 1H, NCH2), 3.64
(ddd, J¼10.3, 8.9, 5.5 Hz, 1H, H-4), 3.91 (dt, J¼10.3, 6.1 Hz, 1H, H-3),
6.58 (td, J¼7.4, 1.2 Hz, 1H, H-5(Ar)), 6.62 (d, J¼8.0 Hz, 1H, H-3(Ar)),
6.92e6.98 (m, 1H, H-4(Ar)), 6.96 (d, J¼7.5 Hz, 1H, H-6(Ar)), 11.12 (br
s, 1H, OH); 13C NMR (101 MHz, DMSO-d6) d 24.0, 25.0, 25.5, 40.8,
41.7, 44.5, 45.6, 57.8, 61.7,115.7, 117.4, 125.8,127.4,130.3,156.0,169.1.
Anal. Calcd for C17H24N2O2,0.2H2O: C, 69.93; H, 8.42; N, 9.59.
Found: C, 70.13; H, 8.67; N, 9.61.
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